BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 33782812)

  • 1. LncRNA SNHG6 promotes breast cancer progression and epithelial-mesenchymal transition via miR-543/LAMC1 axis.
    Wang YQ; Huang G; Chen J; Cao H; Xu WT
    Breast Cancer Res Treat; 2021 Jul; 188(1):1-14. PubMed ID: 33782812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA SNHG6 is Associated with Poor Prognosis of Gastric Cancer and Promotes Cell Proliferation and EMT through Epigenetically Silencing p27 and Sponging miR-101-3p.
    Yan K; Tian J; Shi W; Xia H; Zhu Y
    Cell Physiol Biochem; 2017; 42(3):999-1012. PubMed ID: 28683446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of lncRNA snoRNA host gene 6 regulates NUAK family SnF1-like kinase-1 expression by competitively binding microRNA-125b and interacting with Snail1/2 in bladder cancer.
    Wang C; Tao W; Ni S; Chen Q
    J Cell Biochem; 2019 Jan; 120(1):357-367. PubMed ID: 30168179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNA SNHG6 enhances cell proliferation, migration and invasion by regulating miR-26a-5p/MAPK6 in breast cancer.
    Lv P; Qiu X; Gu Y; Yang X; Xu X; Yang Y
    Biomed Pharmacother; 2019 Feb; 110():294-301. PubMed ID: 30522015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA SNHG6 Induces Epithelial-Mesenchymal Transition of Pituitary Adenoma Via Suppressing MiR-944.
    Mao D; Jie Y; Lv Y
    Cancer Biother Radiopharm; 2022 May; 37(4):246-255. PubMed ID: 32935999
    [No Abstract]   [Full Text] [Related]  

  • 6. LncRNA SNHG6 knockdown inhibits cisplatin resistance and progression of gastric cancer through miR-1297/BCL-2 axis.
    Mei J; Liu G; Li R; Xiao P; Yang D; Bai H; Hao Y
    Biosci Rep; 2021 Dec; 41(12):. PubMed ID: 34821362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA SNHG6 regulating Hedgehog signaling pathway and affecting the biological function of gallbladder carcinoma cells through targeting miR-26b-5p.
    Liu XF; Wang K; Du HC
    Eur Rev Med Pharmacol Sci; 2020 Jul; 24(14):7598-7611. PubMed ID: 32744686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNA SNHG6 promotes glioma tumorigenesis by sponging miR-101-3p.
    Meng Q; Yang BY; Liu B; Yang JX; Sun Y
    Int J Biol Markers; 2018 May; 33(2):148-155. PubMed ID: 29799357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silencing of Long Noncoding RNA SNHG6 Inhibits Esophageal Squamous Cell Carcinoma Progression via miR-186-5p/HIF1α Axis.
    Du F; Guo T; Cao C
    Dig Dis Sci; 2020 Oct; 65(10):2844-2852. PubMed ID: 31853782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-coding RNA SNHG6 promotes the growth and invasion of non-small cell lung cancer by downregulating miR-101-3p.
    Li K; Jiang Y; Xiang X; Gong Q; Zhou C; Zhang L; Ma Q; Zhuang L
    Thorac Cancer; 2020 May; 11(5):1180-1190. PubMed ID: 32147945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA SNHG6 promotes proliferation, invasion and migration in colorectal cancer cells by activating TGF-β/Smad signaling pathway via targeting UPF1 and inducing EMT via regulation of ZEB1.
    Wang X; Lai Q; He J; Li Q; Ding J; Lan Z; Gu C; Yan Q; Fang Y; Zhao X; Liu S
    Int J Med Sci; 2019; 16(1):51-59. PubMed ID: 30662328
    [No Abstract]   [Full Text] [Related]  

  • 12. lncRNA H19 regulates epithelial-mesenchymal transition and metastasis of bladder cancer by miR-29b-3p as competing endogenous RNA.
    Lv M; Zhong Z; Huang M; Tian Q; Jiang R; Chen J
    Biochim Biophys Acta Mol Cell Res; 2017 Oct; 1864(10):1887-1899. PubMed ID: 28779971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA NEAT1 promotes cell proliferation, migration, and invasion via the miR-186-5p/PTP4A1 axis in cholangiocarcinoma.
    Li O; Jiang B; Yi WM; Zhang Y; Yang PZ; Guo C; Sun ZP; Peng C
    Kaohsiung J Med Sci; 2021 May; 37(5):379-391. PubMed ID: 33502823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long noncoding RNA AC073284.4 suppresses epithelial-mesenchymal transition by sponging miR-18b-5p in paclitaxel-resistant breast cancer cells.
    Wang YY; Yan L; Yang S; Xu HN; Chen TT; Dong ZY; Chen SL; Wang WR; Yang QL; Chen CJ
    J Cell Physiol; 2019 Dec; 234(12):23202-23215. PubMed ID: 31215650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silencing lncRNA SNHG6 suppresses proliferation and invasion of breast cancer cells through miR-26a/VASP axis.
    Li K; Ma YB; Tian YH; Xu XL; Gao Y; He YQ; Pan WT; Zhang JW; He CJ; Wei L
    Pathol Res Pract; 2019 Oct; 215(10):152575. PubMed ID: 31387807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silencing long non-coding RNA SNHG6 restrains proliferation, migration and invasion of Wilms' tumour cell lines by regulating miR-15a.
    Su L; Wu A; Zhang W; Kong X
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2670-2677. PubMed ID: 31257923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long noncoding RNA ADPGK-AS1 promotes cell proliferation, migration, and EMT process through regulating miR-3196/OTX1 axis in breast cancer.
    Yang J; Wu W; Wu M; Ding J
    In Vitro Cell Dev Biol Anim; 2019 Aug; 55(7):522-532. PubMed ID: 31264061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long noncoding RNA H19 acts as a miR-340-3p sponge to promote epithelial-mesenchymal transition by regulating YWHAZ expression in paclitaxel-resistant breast cancer cells.
    Yan L; Yang S; Yue CX; Wei XY; Peng W; Dong ZY; Xu HN; Chen SL; Wang WR; Chen CJ; Yang QL
    Environ Toxicol; 2020 Sep; 35(9):1015-1028. PubMed ID: 32420678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of microRNA-190 inhibits migration, invasion, epithelial-mesenchymal transition, and angiogenesis through suppression of protein kinase B-extracellular signal-regulated kinase signaling pathway via binding to stanniocalicin 2 in breast cancer.
    Sun G; Liu M; Han H
    J Cell Physiol; 2019 Aug; 234(10):17824-17838. PubMed ID: 30993707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA SNHG6 Promotes Wilms' Tumor Progression Through Regulating miR-429/FRS2 Axis.
    Wang Y; Liu J; Yao Q; Wang Y; Liu Z; Zhang L
    Cancer Biother Radiopharm; 2024 May; 39(4):264-275. PubMed ID: 33481659
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.